Tamaki Y - Search Results

1

High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.

Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y, Nakamura H, Yodoi J, Kato K, Noguchi S. Kim SJ, et al. Among authors: tamaki y. Clin Cancer Res. 2005 Dec 1;11(23):8425-30. doi: 10.1158/1078-0432.CCR-05-0449. Clin Cancer Res. 2005. PMID: 16322305

2

Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.

Miyoshi Y, Ando A, Takamura Y, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: tamaki y. Int J Cancer. 2002 Jan 1;97(1):129-32. doi: 10.1002/ijc.1568. Int J Cancer. 2002. PMID: 11774254

3

High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.

Egawa C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Egawa C, et al. Among authors: tamaki y. Int J Cancer. 2002 Apr 20;98(6):879-82. doi: 10.1002/ijc.10231. Int J Cancer. 2002. PMID: 11948466

4

High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.

Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H, Noguchi S. Miyoshi Y, et al. Among authors: tamaki y, tamaki h. Clin Cancer Res. 2002 May;8(5):1167-71. Clin Cancer Res. 2002. PMID: 12006533

5

Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.

Yoneda K, Tanji Y, Ikeda N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Yoneda K, et al. Among authors: tamaki y. Cancer Lett. 2002 Dec 5;186(2):223-30. doi: 10.1016/s0304-3835(02)00345-2. Cancer Lett. 2002. PMID: 12213292

6

Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers.

Egawa C, Motomura K, Miyoshi Y, Takamura Y, Taguchi T, Tamaki Y, Inaji H, Koyama H, Noguchi S. Egawa C, et al. Among authors: tamaki y. Breast Cancer Res Treat. 2003 Mar;78(1):45-50. doi: 10.1023/a:1022101310500. Breast Cancer Res Treat. 2003. PMID: 12611456

7

Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.

Ishitobi M, Miyoshi Y, Ando A, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S. Ishitobi M, et al. Among authors: tamaki y. Clin Cancer Res. 2003 Apr;9(4):1376-80. Clin Cancer Res. 2003. PMID: 12684407

8

Current status of endocrine therapy for breast cancer.

Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: tamaki y. Breast Cancer. 2003;10(2):105-11. doi: 10.1007/BF02967634. Breast Cancer. 2003. PMID: 12736562 Review.

9

Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue.

Miyoshi Y, Ando A, Ooka M, Shiba E, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: tamaki y. Cancer Lett. 2003 May 30;195(1):81-6. doi: 10.1016/s0304-3835(02)00211-2. Cancer Lett. 2003. PMID: 12767515

10

Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.

Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: tamaki y. Clin Cancer Res. 2003 Jun;9(6):2229-33. Clin Cancer Res. 2003. PMID: 12796390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

995 results

Search Page

Filters